2023-05-10

New BD survey finds nearly half of women unaware of STI treatment options

FiercePharma

Nearly half of women don’t know what treatment options are available for STIs – we need better education.

FiercePharma reports on new Harris Poll findings revealing extreme knowledge gaps in women’s understanding of STIs, testing and treatment options.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay
Cervical Cancer | News & Updates
Press release: BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay
Business Insider
Cervical Cancer | News & Updates
Business Insider: Getting the HPV vaccine and regular testing can help protect you from high-risk HPV strains that cause cancer
Contemporary OB/GYN: BD Onclarity™ HPV Assay: What it means for the future of cervical cancer detection
Cervical Cancer | News & Updates
Contemporary OB/GYN: BD Onclarity™ HPV Assay: What it means for the future of cervical cancer detection